Quantum Genomics Share Price Deutsche Boerse AG
Equities
2QG
FR0011648971
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.1164 EUR | +1.22% | -0.51% | +32.27% |
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 4.34M 4.67M 372M |
---|---|---|---|---|---|
Net income 2024 * | -3M -3.23M -257M | Net income 2025 * | - | EV / Sales 2024 * | - |
Net cash position 2024 * | 8.7M 9.37M 746M | Net cash position 2025 * | - 0 0 | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-1.38
x | P/E ratio 2025 * |
-
| Employees | 3 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 87.23% |
1 day | +1.22% | ||
1 week | -0.51% | ||
Current month | +5.82% | ||
1 month | +25.70% | ||
3 months | -3.00% | ||
6 months | +53.36% | ||
Current year | +32.27% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 63 | - | |
Lionel Ségard
FOU | Founder | 56 | 22/12/05 |
Benoît Gueugnon
DFI | Director of Finance/CFO | - | 30/06/18 |
Members of the board | Title | Age | Since |
---|---|---|---|
Lionel Ségard
FOU | Founder | 56 | 22/12/05 |
François Pelen
BRD | Director/Board Member | 67 | - |
Chief Executive Officer | 63 | - |
Date | Price | Change |
---|---|---|
03/05/24 | 0.1164 | +1.22% |
02/05/24 | 0.115 | +4.55% |
30/04/24 | 0.11 | 0.00% |
29/04/24 | 0.11 | -5.98% |
Delayed Quote Deutsche Boerse AG, May 03, 2024 at 08:15 am
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+25.69% | 47.9B | |
+46.90% | 41.42B | |
-3.46% | 40.7B | |
-6.20% | 28.92B | |
+9.17% | 25.55B | |
-20.42% | 19.27B | |
+0.17% | 12.15B | |
+28.07% | 12.14B | |
-1.24% | 11.99B |
- Stock Market
- Equities
- ALQGC Stock
- 2QG Stock